Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01784991 · ClinicalTrials.gov registry record · NA
Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
A NA study, sponsored by Albert Einstein Healthcare Network.
- Terminated
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT01784991 is a NA study that was terminated before completion, run by Albert Einstein Healthcare Network. The registered enrollment target is 116 participants.
The verdict
NCT01784991, a NA study, was terminated before completion, sponsored by Albert Einstein Healthcare Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
This is a study about the efficiency and safety of a 1mg+1mg hydromorphone pain management protocol for the treatment of moderate to sever pain in the Emergency Department. Appropriate patients 60 years and older who present with a condition that causes moderate to severe pain, according to the attending physician's judgment, in which the physician would order the use of parenteral analgesia will be enrolled in one of two study arms, "1+1" versus usual care group. 1+1 patients will receive 1mg hydromorphone followed by another 1mg after 15 minutes if pain persists. Usual care group patients will have pain treated per the discretion of the attending physician. Respiratory status, vital signs, and pain scores will be monitor to assess the efficiency of pain control as well as the safety of pain medicine administration in terms of respiratory depression.
Interventions
- DRUG Hydromorphone
- DRUG Usual care group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01784991
The ClinicalTrials.gov registry entry for NCT01784991 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT01784991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01784991 about?
NCT01784991 is a clinical study titled "Study of Respiratory Depression When Using a Hydromorphone Pain Protocol". This is a study about the efficiency and safety of a 1mg+1mg hydromorphone pain management protocol for the treatment of moderate to sever pain in the Emergency Department. Appropriate patients 60 years and older who present with a condition that causes moderate to severe pain, according to the atte...
What is the current status of trial NCT01784991?
This trial is currently terminated. It is a NA study. The enrollment target is 116 participants. The study started on 2011-12. Estimated completion is 2014-04-16.
What interventions are being tested in trial NCT01784991?
The interventions under investigation include: Hydromorphone (DRUG), Usual care group (DRUG).
Who is sponsoring clinical trial NCT01784991?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.